Profile data is unavailable for this security.
About the company
STERIS Plc is a provider of products and services that support patient care with an emphasis on infection prevention. Its segments include Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. Its Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. AST segment supports medical device and pharmaceutical manufacturers through a global network of contract sterilization and laboratory testing facilities, and integrated sterilization equipment and control systems. Its Life Sciences segment provides a comprehensive offering of products and services designed to support biopharmaceutical and medical device research and manufacturing facilities, in particular those focused on aseptic manufacturing. Its portfolio includes a full suite of consumable products, equipment maintenance, specialty services, and capital equipment.
- Revenue in USD (TTM)5.46bn
- Net income in USD610.12m
- Incorporated2016
- Employees17.79k
- LocationSTERIS plc70 Sir John Rogerson's QuayDUBLIN 2IrelandIRL
- Phone+353 12322000
- Websitehttps://www.steris.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Solventum Corp | 8.31bn | 379.00m | 13.58bn | 22.00k | 36.08 | 4.16 | 14.71 | 1.63 | 2.18 | 2.18 | 47.69 | 18.85 | 0.5683 | 4.26 | 7.74 | 377,636.40 | 2.59 | -- | 3.05 | -- | 54.71 | -- | 4.55 | -- | 0.8523 | 1.93 | 0.7081 | -- | 0.6954 | -- | -64.41 | -- | -- | -- |
| Align Technology Inc | 3.98bn | 409.56m | 14.27bn | 20.95k | 35.82 | 3.79 | 25.44 | 3.58 | 5.49 | 5.49 | 53.41 | 51.94 | 0.6495 | 4.55 | 3.96 | 190,061.70 | 6.68 | 13.90 | 9.94 | 20.50 | 69.92 | 71.24 | 10.29 | 20.95 | 1.08 | -- | 0.00 | 0.00 | 3.54 | 10.69 | -5.32 | -0.9865 | -5.04 | -- |
| Hologic Inc | 4.03bn | 556.70m | 14.44bn | 7.06k | 27.35 | 3.13 | 16.91 | 3.59 | 2.37 | 2.37 | 17.31 | 20.73 | 0.4666 | 2.57 | 6.24 | 570,083.60 | 6.45 | 13.12 | 7.27 | 15.20 | 56.44 | 60.82 | 13.83 | 24.75 | 2.52 | 110.53 | 0.354 | 0.00 | -0.0025 | 3.66 | 73.14 | -- | 4.30 | -- |
| Cooper Companies Inc | 3.99bn | 414.20m | 14.62bn | 16.00k | 35.54 | 1.76 | 18.80 | 3.67 | 2.06 | 2.06 | 19.86 | 41.54 | 0.3261 | 1.58 | 5.43 | 249,262.50 | 3.39 | 8.72 | 3.68 | 9.73 | 67.20 | 65.70 | 10.39 | 26.35 | 1.23 | 6.80 | 0.2378 | 0.282 | 8.41 | 7.98 | 33.34 | -3.17 | 7.59 | -- |
| Baxter International Inc | 10.77bn | -277.00m | 15.91bn | 38.00k | -- | 2.25 | 22.57 | 1.48 | -0.5388 | -1.10 | 21.03 | 13.80 | 0.4388 | 2.64 | 5.04 | 283,447.40 | -1.09 | -0.8441 | -1.37 | -1.03 | 36.73 | 38.63 | -2.49 | -2.03 | 1.40 | 3.65 | 0.5882 | -- | 2.66 | -1.31 | -293.68 | -- | -8.52 | 4.12 |
| Illumina Inc | 4.34bn | -965.00m | 15.96bn | 8.97k | -- | 6.77 | -- | 3.68 | -6.10 | -6.10 | 27.23 | 14.89 | 0.5347 | 2.60 | 6.36 | 483,500.60 | -11.90 | -10.33 | -14.50 | -12.15 | 66.34 | 65.65 | -22.25 | -25.30 | 1.48 | 17.30 | 0.4566 | -- | -2.93 | 4.29 | -5.34 | -- | -9.34 | -- |
| West Pharmaceutical Services Inc | 2.90bn | 467.20m | 15.97bn | 10.60k | 34.92 | 5.95 | 26.04 | 5.51 | 6.37 | 6.37 | 39.47 | 37.37 | 0.8021 | 4.63 | 5.30 | 273,188.70 | 12.56 | 15.61 | 15.00 | 18.70 | 34.54 | 38.00 | 15.66 | 18.84 | 2.03 | -- | 0.0716 | 10.20 | -1.92 | 9.48 | -16.97 | 15.31 | 24.43 | 5.84 |
| Zimmer Biomet Holdings Inc | 7.70bn | 913.40m | 18.53bn | 17.00k | 20.76 | 1.50 | 9.62 | 2.41 | 4.51 | 4.51 | 38.06 | 62.63 | 0.3529 | 0.9622 | 5.17 | 452,852.90 | 4.19 | 2.34 | 4.75 | 2.68 | 71.05 | 71.18 | 11.88 | 7.60 | 1.46 | 6.46 | 0.3665 | 37.52 | 3.85 | -0.7725 | -11.74 | 2.05 | -3.69 | 0.00 |
| Waters Corp | 2.98bn | 657.02m | 20.84bn | 7.60k | 31.79 | 10.62 | 24.49 | 6.99 | 11.02 | 11.02 | 50.04 | 32.98 | 0.6556 | 2.31 | 4.45 | 392,533.30 | 14.44 | 18.41 | 18.02 | 23.46 | 59.27 | 58.71 | 22.02 | 22.81 | 1.28 | 13.77 | 0.426 | 0.00 | 0.0667 | 4.22 | -0.6851 | 1.61 | -2.75 | -- |
| Insulet Corp | 2.20bn | 402.20m | 21.18bn | 3.90k | 54.18 | 15.92 | 43.59 | 9.63 | 5.56 | 5.56 | 29.72 | 18.91 | 0.7161 | 1.49 | 6.08 | 563,820.50 | 13.10 | 6.00 | 15.50 | 7.03 | 70.39 | 67.05 | 18.29 | 9.22 | 3.63 | 49.39 | 0.5603 | 0.00 | 22.07 | 22.92 | 102.76 | 104.84 | -4.75 | -- |
| Steris PLC | 5.46bn | 610.12m | 23.37bn | 17.79k | 38.57 | 3.54 | 21.48 | 4.28 | 6.16 | 6.20 | 55.11 | 67.18 | 0.5148 | 4.87 | 5.32 | 306,938.50 | 5.77 | 5.04 | 6.36 | 5.51 | 44.01 | 43.75 | 11.20 | 10.69 | 1.39 | 12.76 | 0.236 | 37.51 | 6.24 | 12.49 | 10.64 | 8.40 | 11.52 | 8.99 |
| DexCom Inc | 4.15bn | 535.20m | 32.52bn | 10.30k | 63.59 | 14.35 | 42.76 | 7.84 | 1.30 | 1.30 | 10.11 | 5.78 | 0.6269 | 2.89 | 3.89 | 402,718.40 | 8.09 | 8.79 | 12.44 | 11.75 | 60.72 | 64.97 | 12.90 | 14.90 | 1.32 | -- | 0.5246 | 0.00 | 11.34 | 22.27 | 6.41 | 41.63 | 14.79 | -- |
| Agilent Technologies Inc | 6.63bn | 1.17bn | 34.48bn | 18.00k | 29.87 | 5.62 | 23.89 | 5.20 | 4.06 | 4.06 | 23.09 | 21.61 | 0.576 | 3.08 | 5.07 | 370,279.30 | 10.13 | 10.93 | 12.25 | 13.09 | 53.77 | 53.35 | 17.59 | 17.93 | 1.60 | 24.95 | 0.3629 | 21.83 | -4.73 | 4.75 | 3.95 | 3.77 | 19.36 | 7.80 |
Data as of Jul 03 2025. Currency figures normalised to STERIS plc's reporting currency: US Dollar USD
42.76%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2025 | 11.50m | 11.71% |
| BlackRock Fund Advisorsas of 31 Mar 2025 | 5.76m | 5.86% |
| WCM Investment Management LLCas of 31 Mar 2025 | 4.50m | 4.59% |
| SSgA Funds Management, Inc.as of 31 Mar 2025 | 4.09m | 4.16% |
| Massachusetts Financial Services Co.as of 31 Mar 2025 | 3.98m | 4.05% |
| Generation Investment Management LLPas of 31 Mar 2025 | 3.35m | 3.41% |
| Morgan Stanley Investment Management Ltd.as of 31 Mar 2025 | 2.60m | 2.65% |
| Geode Capital Management LLCas of 31 Mar 2025 | 2.43m | 2.48% |
| Select Equity Group LPas of 31 Mar 2025 | 2.22m | 2.26% |
| APG Asset Management NVas of 31 Mar 2025 | 1.57m | 1.60% |
More ▼
Data from 31 Mar 2025 - 31 Mar 2025Source: FactSet Research Systems Inc.
